Volume 179, Issue 8, August 2022

EDITOR’S NOTE

1. Neurodevelopmental and Neurodegenerative Illnesses: Autism, Fragile X Syndrome, Parkinson’s Disease, and Dementia

EDITORIALS

2. The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia

3. Amygdala Involvement in Autism: Early Postnatal Changes, But What Are the Behavioral Consequences?

4. Infant Brain Signatures of Genetic Liability for Autism: The Critical Need for Longitudinal Research

REVIEWS AND OVERVIEWS

5. Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management

ARTICLES

6. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes

7. Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries

8. Subcortical Brain Development in Autism and Fragile X Syndrome: Evidence for Dynamic, Age- and Disorder-Specific Trajectories in Infancy

9. Infant Visual Brain Development and Inherited Genetic Liability in Autism

APA OFFICIAL ACTIONS

10. The Psychiatric Bed Crisis in the United States: Understanding the Problem and Moving Toward Solutions

- American Psychiatric Association Presidential Report on the Assessment of Psychiatric Bed Needs in the United States

OTHER ITEMS OF INTEREST

11. Correction to Lebois et al.